MarketPeel
Insider Trading Intelligence
Pricing
…
PL

Peter F. Lebowitz

BBOT
DIRECTOR · BRIDGEBIO ONCOLOGY THERAPEUTICS, INC. · CIK 0002121402
FILING MIX · LIFETIME100%/0%
BUYS
2
SELLS
0
TOTAL VALUE
$0
COMPANIES
1
ACTIVE SINCE
Mar 2026
HOLDINGS NOW
7,289
AVG SELL PX
—
TRADE KIND
SHOWING 2 / 2
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
No backtest data available for Peter F. Lebowitz. Backtests are computed for purchase (P) and sale (S) transactions with resolvable price history.
Holdings over time
BBOT · 7,289 shares · as of Jun 16, 2026
015,83831,67547,51363,350SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2026
2026
FLOW · 2 buys / 0 sellsCOVERAGE · 2 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
BBOT
BRIDGEBIO ONCOLOGY THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
7,289——7,289Jun 16, 2026Jun 18, 2026 ↗View →
BBOT
BRIDGEBIO ONCOLOGY THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
63,350——63,350Mar 24, 2026Mar 26, 2026 ↗View →
Other insiders · BBOT
Loading peer insiders…
About this filer
CIK 0002121402
ROLE
Director
PRIMARY
BBOT
COMPANIES
1
ACTIVE SINCE
Mar 2026
MARKETPEEL · /INSIDER/0002121402DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback